VALUATION DIAGNOSTIC
Biotech & Contract Research
Specific market analysis for Biotech & Contract Research companies based in St. Gallen.
Pro-Forma Valuation
Market demand in St. Gallen for Biotech & Contract Research assets remains strong.
KEY DRIVER
"Basel pharma ecosystem, highest multiples on platform, GLP/GMP regulatory moats, biologics pipeline demand."
Local Multiples (Est.)
7.0 - 10.0x Statutory
Get Your Report
Generate a certified valuation for your Biotech & Contract Research business in St. Gallen.
Valuation Impact by Size (DACH 2025)
| Size Bucket | Multiple Range | Impact |
|---|---|---|
| Micro (< CHF 1M EBITDA) | 4.3x - 5.8x | -33.3% |
| Small (CHF 1M - 2M EBITDA) | 5.9x - 8.0x | -6.7% |
| Transition (CHF 2M - 5M EBITDA) | 7.2x - 9.8x | +11.1% |
| Lower Mid-Market (CHF 5M - 10M EBITDA) | 9.9x - 13.3x | +33.3% |
| Mid-Market (> CHF 10M EBITDA) | 12.5x - 16.9x | +66.7% |
Source: NIMBO, Dealsuite, KPMG, SECA, Practitioner Interviews // Niche Baseline: 8.5x
Biotech & Contract Research Market in St. Gallen
St. Gallen — known for textile manufacturing heritage, precision engineering tradition — represents a significant market for Biotech & Contract Research companies in Switzerland. The local business environment is shaped by the canton's economic profile, offering distinct opportunities for both buyers and sellers in this niche.
Current EBITDA multiples for Biotech & Contract Research businesses range from 7.0 - 10.0x (statutory) to 9.0 - 14.0x (deal), reflecting a significant arbitrage opportunity. The sector trend is rising, driven by: Basel pharma ecosystem, highest multiples on platform, GLP/GMP regulatory moats, biologics pipeline demand. This positions St. Gallen as a notable market within the broader Life Sciences & Pharma sector.
St. Gallen — Economy Snapshot
- Corporate Tax
- 17.4%
- #18/26
- Companies
- 38'500
- 99% SME
- Unemployment
- 2.3%
- Median Salary
- CHF 6'350
- /month
- Succession Risk
- 31%
- owners 55+
Why Biotech & Contract Research in St. Gallen?
St. Gallen offers a diversified economic base with 38'500 total companies. While not a primary hub for Biotech & Contract Research, the canton's competitive tax environment and skilled workforce create favorable conditions for business operations and valuations.
- Home to the University of St. Gallen (HSG), consistently ranked among Europe's top 5 business schools, providing exceptional entrepreneurial and financial talent
- Highly diversified economy spanning precision engineering, financial services, IT, healthcare, and textiles, reducing sector-specific risk
- Strategic location on the Zurich-Munich-Vienna corridor with excellent rail, motorway, and regional airport connectivity
Tax Impact on Valuation
At St. Gallen's effective corporate tax rate of 17.4% (rank #18/26), after-tax EBITDA retention is 82.6%. This directly influences enterprise valuations and buyer economics in the Biotech & Contract Research sector.
FAQ: Biotech & Contract Research in St. Gallen
How many Biotech & Contract Research companies are in St. Gallen?
St. Gallen has 38'500 total companies. Specific Biotech & Contract Research company counts are part of the broader industrial landscape.
What is the corporate tax rate in St. Gallen?
The effective corporate tax rate in St. Gallen is 17.4%, ranking #18 among Switzerland's 26 cantons.
What are Biotech & Contract Research valuation multiples in St. Gallen?
Current statutory EBITDA multiples for Biotech & Contract Research range from 7.0 - 10.0x. Deal-based multiples are 9.0 - 14.0x. These are influenced by St. Gallen's tax environment and local market conditions.
What is the business succession outlook in St. Gallen?
St. Gallen faces a substantial succession wave with approximately 4,800 companies at risk over the coming decade. The canton's diverse SME landscape spans textiles, precision engineering, services, and food production, creating varied succession needs. The University of St. Gallen (HSG) produces many entrepreneurially minded graduates, which partly offsets the challenge. However, in more rural districts and in traditional industries like textiles, finding successors remains difficult. The canton's M&A advisory market is active, benefiting from proximity to Zurich's financial ecosystem.
Canton hub: tax data, industry composition, key employers
Full Swiss market analysis across all 26 cantons, including comparable M&A transactions and sector trends.
Biotech & Contract Research Valuations Across Switzerland
Compare Biotech & Contract Research business valuation benchmarks in other Swiss cantons and cities.
Other Industries in St. Gallen
Explore valuation data for different sectors based in St. Gallen.